TY - JOUR
T1 - Parotid region lymphatic mapping and sentinel lymphadenectomy for cutaneous melanoma
AU - Ollila, David W.
AU - Foshag, Leland J.
AU - Essner, Richard
AU - Stern, Stacey L.
AU - Morton, Donald L.
N1 - Funding Information:
Received March 28, 1998; accepted August 27, 1998. From the Roy E. Coats Research Laboratories of the John Wayne Cancer Institute, St. John’s Health Center, Santa Monica, California. *Currently at the University of North Carolina, Chapel Hill, North Carolina. Supported by Grants CA12562 and CA29605 from the National Cancer Institute and by funding from the Wrather Family Foundation (Los Angeles, CA). Presented at the 51st Annual Cancer Symposium of The Society of Surgical Oncology, San Diego, California, March 26-29, 1998. Address correspondence and reprint requests to: Donald L. Morton, MD, John Wayne Cancer Institute, 2200 Santa Monica Blvd., Santa Monica, CA 90404.
PY - 1999/3
Y1 - 1999/3
N2 - Background: Routine elective superficial parotidectomy for patients with primary cutaneous melanomas of the scalp, auricle, or face has been questioned. We evaluated an alternative, i.e., lymphatic mapping and sentinel lymphadenectomy, for patients with primary cutaneous melanomas draining to the region of the parotid gland. Patients: Retrospective review of our large (>8000 patients) melanoma database identified 39 patients with primary melanomas (American Joint Committee on Cancer stage I or II) of the scalp (n = 19), auricle (n = 11), or face (n = 9) who underwent intraoperative lymphatic mapping to identify a sentinel node (SN) in the region of the parotid gland, between June 1985 and July 1997. Results: A SN was identified in the parotid region of 37 patients (94.9%), four of whom had SN metastases. The mean number of SN obtained was 2.3/patient (range, 1-4/patient). The two patients (5.1%) for whom a parotid-region SN could not be identified underwent superficial parotidectomy during the same operation. Among the 33 patients with tumor-free SN, with a median follow-up period of 33.2 months (range, 1-121 months), there was one (3.1%) intraparotid recurrence; thus, the false-negative rate was 3.1%. The procedure-related surgical morbidity rate was only 2.6% (one case of temporary facial nerve paresis). Conclusions: For patients with primary melanomas of the scalp, auricle, or face, sentinel lymphadenectomy can be performed accurately in the parotid region and offers a low-morbidity alternative to routine elective superficial parotidectomy.
AB - Background: Routine elective superficial parotidectomy for patients with primary cutaneous melanomas of the scalp, auricle, or face has been questioned. We evaluated an alternative, i.e., lymphatic mapping and sentinel lymphadenectomy, for patients with primary cutaneous melanomas draining to the region of the parotid gland. Patients: Retrospective review of our large (>8000 patients) melanoma database identified 39 patients with primary melanomas (American Joint Committee on Cancer stage I or II) of the scalp (n = 19), auricle (n = 11), or face (n = 9) who underwent intraoperative lymphatic mapping to identify a sentinel node (SN) in the region of the parotid gland, between June 1985 and July 1997. Results: A SN was identified in the parotid region of 37 patients (94.9%), four of whom had SN metastases. The mean number of SN obtained was 2.3/patient (range, 1-4/patient). The two patients (5.1%) for whom a parotid-region SN could not be identified underwent superficial parotidectomy during the same operation. Among the 33 patients with tumor-free SN, with a median follow-up period of 33.2 months (range, 1-121 months), there was one (3.1%) intraparotid recurrence; thus, the false-negative rate was 3.1%. The procedure-related surgical morbidity rate was only 2.6% (one case of temporary facial nerve paresis). Conclusions: For patients with primary melanomas of the scalp, auricle, or face, sentinel lymphadenectomy can be performed accurately in the parotid region and offers a low-morbidity alternative to routine elective superficial parotidectomy.
KW - Melanoma
KW - Parotid gland
KW - Sentinel node
UR - https://www.scopus.com/pages/publications/0032914557
U2 - 10.1007/s10434-999-0150-0
DO - 10.1007/s10434-999-0150-0
M3 - Article
C2 - 10082039
AN - SCOPUS:0032914557
SN - 1068-9265
VL - 6
SP - 150
EP - 154
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
IS - 2
ER -